Global Antithrombin Market

1. Summary

The Global Antithrombin Market was valued at $720 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.5% CAGR, to an estimated market size of $941 mn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global antithrombin market encompasses the production, distribution, and clinical application of therapeutic proteins – both plasma-derived and recombinant – used to inhibit blood coagulation. The scope includes treatments for hereditary antithrombin deficiency, acquired deficiencies related to sepsis, disseminated intravascular coagulation (DIC), and complications arising during extracorporeal membrane oxygenation (ECMO) or major cardiac surgeries.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Antithrombin Market in the period 2025-30:

• The rising prevalence of thromboembolic disorders and chronic conditions like heart and kidney disease is driving consistent demand for anticoagulant therapies.
• There is a significant clinical shift toward recombinant antithrombin due to its superior purity, safety profile, and reduced risk of viral contamination compared to plasma-derived alternatives.
• Increased utilization of antithrombin in cardiovascular surgeries and ECMO procedures is expanding the therapeutic application beyond simple deficiency management.
• The Asia-Pacific region is emerging as a high-growth market due to improving healthcare infrastructure and rising clinical awareness in China and India.
• Technological integration of bioinformatics and gene editing is accelerating the development of engineered antithrombin variants with extended half-lives.
• The legacy of the COVID-19 pandemic has heightened clinical focus on managing hypercoagulable states and clotting abnormalities in severe viral infections.
• Strategic collaborations among key players like Grifols and CSL Behring are focusing on specialized liquid formulations to improve clinical efficiency and ease of administration.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: